However, TNFα‐CSG treatment and adoptive transfer of both CD8+ and CD4+ T cells (triple combination) produced anti‐tumour effects similar to those observed in syngeneic 4T1 tumour‐bearing mice (Fig 8B). The gene discussed is CD4; the disease is neoplasm.